All In MedTech

Device Trial Radar · NCT06271590

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

The MAGICAL SV Trial - A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Non Inferiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus-Coated Balloon in the Treatment of Small Vessels in Patients With Coronary Artery Disease.

Last checked: Nov 20, 2026Latest source record: Sep 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,605 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,605

Planned (sponsor's estimate)

Start

May 20, 2025

Primary completion

Nov 2028

Study completion Nov 2031

Sponsor

Lead sponsor
Concept Medical Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Cardiovascular Research Foundation, New York
First posted
Feb 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated balloon in treatment of small vessels (≤2.75 mm). A total of 1605 subjects will be enrolled in a maximum of 50 study sites located in North America. Additional sites located in Europe and South America may also participate in the study, with non-US sites contributing a maximum of \~50% of enrollees.

Conditions

  • Coronary Artery Disease
  • Native Coronary Artery Stenosis
  • Cardiovascular Diseases

Interventions

  • Sirolimus Drug Coated BalloonDevice

    Magic TouchTM (Concept Medical) is a semi-compliant sirolimus drug coated balloon (SCB) for PCI, based on a polymer-free and nanocarrier based drug delivery technology.

  • Drug eluting stents (DES)Device

    For subjects randomized to the control group (DES), the treating physician will choose an FDA cleared DES (ZES or EES) and follow lesion preparation and stent deployment according to the Instructions per use (IFU) and institutional practices.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target lesion failure (TLF)Time frame: within 12 months

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Dignity Health - Mercy Gilbert Medical Center

    Gilbert, Arizona · Not yet recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Not yet recruiting

  • Clearwater Cardiovascular and Interventional Consultants

    Clearwater, Florida · Recruiting

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.